/ Not yet recruitingPhase 3 CLINICAL TRIAL TO ASSEES THE NON-INFERIORITY OF THE SUSPENSION OF PROPHYLACTIC TREATMENT WITH VALGANCICLOVIR IN KIDNEY TRANSPLANT CMV-seropositive PATIENTS, WHO MANTEIN CD8+ CMV- CELLULAR IMMUNITY AFTER THYMOGLOBULIN TREATMENT.
/ Not yet recruitingPhase 2 An open, Phase II, clinical trial to evaluate the effectiveness of decreased intestinal absorption of phosphorus in the progression of renal disease in patients with metabolic syndrome
100 Clinical Results associated with FIBICO Management GmbH
0 Patents (Medical) associated with FIBICO Management GmbH
100 Deals associated with FIBICO Management GmbH
100 Translational Medicine associated with FIBICO Management GmbH